Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01088997 · ClinicalTrials.gov registry record · NA
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
A NA study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01088997 is a NA study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 12 participants.
The verdict
NCT01088997, a NA study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN).
Interventions
- DRUG Milrinone Lactate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01088997
The ClinicalTrials.gov registry entry for NCT01088997 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Milrinone Lactate is the first listed.
NCT01088997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01088997 about?
NCT01088997 is a clinical study titled "Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn". The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN).
What is the current status of trial NCT01088997?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2010-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01088997?
The interventions under investigation include: Milrinone Lactate (DRUG).
Who is sponsoring clinical trial NCT01088997?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.